Antithrombotic agents for secondary prevention of cardioembolic and noncardioembolic stroke--another viewpoint.
Inverso
S M
SM
Philadelphia College of Pharmacy, University of the Science in Philadelphia, Pennsylvania 19104, USA.
Spinler
S A
SA
D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020766:Intracranial Embolism / Q000150:complications / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin